Abstract:Purpose This study attempts to document the impact of financial leverage on corporate innovation in the Chinese nonfinancial public firms listed on Shenzhen and Shanghai stock exchanges. Design/methodology/approach The firm-level data are collected from CSMAR database for ten years, ranging from 2007 to 2016. The authors have employed the panel fixed effects model and further system GMM approach for analysis. The sample is segregated on the basis of state (SOE) and nonstate ownership (NSOE) to check for the diverse effects. In total, three different proxies of financial leverage are used to unearth the varying impact of short-time and long-term leverage separately. Further, corporate innovation is divided into input innovation (R&D/Sales and R&D/Assets) and output innovation (patents and inventions). Findings The results suggest that financial leverage is detrimental to the input innovation while conducive for the output innovation when measured by the number of patents. Contrarily, leverage has a negative influence over the output innovation when measured by the number of inventions. This implies that leverage is more damaging for the highest form of innovativeness (inventions) in China. Input innovation is more sensitive to the changes in long-term leverage versus short-term leverage. Further, the authors find that innovation in SOEs is more sensitive to the changes in the leverage as compared to the NSOEs. The results are free from the threat of endogeneity and identification problems, as reported by the system GMM model. Research limitations/implications The authors did not segregate the sample on the basis of industry/sector. Practical implications The firms pursuing a strategy of radical innovation should try to keep their debt levels lower in order to achieve a higher innovation performance. Although, a rise in the leverage may mean an increased access to finance for a firm but such an access comes at a cost in the form of damage to the corporate innovation. However, increased debt financing may not be so bad for the firms that want to achieve a moderate and not the highest level of innovation. Such firms can produce recurring and synergic effects with debt financing and moderate innovation, once they achieve a level of innovation performance that satisfies their financiers. Originality/value To the best of authors’ knowledge, this is probably the first study to check the impact of firm-level financial leverage on both input and output innovation in the Chinese public-listed nonfinancial firms' panel data perspective till now.

Banks’ Governance and Innovation: Evidence from the Listed Firms in China

The Effects of Corporate Governance on Innovation in Chinese Firms ∗

Do financial innovations influence bank performance? Evidence from China

Bank market structure and firm innovation-evidence from China

Initial Public Offering, Corporate Innovation and Total Factor Productivity: Evidence from China

Risk Culture of Banks and Corporate Innovation: Evidence from Chinese Listed Companies

The impact of imperfect financial markets and stock holdings on corporate innovation: Evidence from China

Short-term loans and Firms' high-quality innovation: Evidence from the access to patent-backed loans in China

Bank price competition and enterprise innovation——Based on empirical evidence of Chinese A-share listed companies

Enterprise Innovation, Government Subsidies, and Bank Loans: an Empirical Analysis from the Science and Technology Innovation Board of China

Bank Competition, Financing Constraints, and Enterprise Innovation Investment

Why Are the Industrial Firms of Emerging Economies Short-Termistic in Innovation? Industry-level Evidence from Chinese Manufacturing.

Banks’ Interventions and Firms’ Innovation: Evidence from Debt Covenant Violations

Bank Digital Transformation and Enterprise Innovation—Evidence from China

Financial Institution Shareholding and Corporate Innovation: Evidence from China

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies

Financial leverage and corporate innovation in Chinese public-listed firms

FINANCING STRUCTURE AND INNOVATION---Evidence from A-share of Listing Corporation of Strategic Emerging Industries in China

The Real Effects of Shadow Banking: Evidence from China

Corporate Nature, Financial Technology, and Corporate Innovation in China

How do banks finance firm innovation: evidence from syndicated loans in China